Eculizumab


( Last Updated : January 7, 2013)
Generic Name:
Eculizumab
Project Status:
Complete
Therapeutic Area:
Hemolytic Uremic Syndrome, Atypical
Manufacturer:
Alexion Pharma Canada
Call for patient/clinician input open:
Brand Name:
Soliris
Project Line:
Reimbursement Review
Project Number:
SR0304-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Hemolytic Uremic Syndrome, Atypical
Recommendation Type:
Do not list
Final Recommendation: